Zobrazeno 1 - 10
of 740
pro vyhledávání: '"V. Larocca"'
Autor:
Daniela A. Bota, Thomas H. Taylor, David E. Piccioni, Christopher M. Duma, Renato V. LaRocca, Santosh Kesari, Jose A. Carrillo, Mehrdad Abedi, Robert D. Aiken, Frank P. K. Hsu, Xiao-Tang Kong, Candace Hsieh, Peter G. Bota, Gabriel I. Nistor, Hans S. Keirstead, Robert O. Dillman
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-9 (2022)
Abstract Background Vaccine immunotherapy may improve survival in Glioblastoma (GBM). A multicenter phase II trial was designed to determine: (1) the success rate of manufacturing the Aivita GBM vaccine (AV-GBM-1), (2) Adverse Events (AE) associated
Externí odkaz:
https://doaj.org/article/5a31d54aac0647619b0bae78c1eddb03
Autor:
Nicola Sgherza, Daniela Di Gennaro, Paola Curci, Rita Rizzi, Daniela Roccotelli, Maria Croce, Martina Avantaggiato, Loredana Ruga, Vanda Strafella, Angelantonio Vitucci, Antonio Palma, Antonella V. Russo Rossi, Teresa Troiano, Angela M. V. Larocca, Maria Chironna, Silvio Tafuri, Francesco Albano, Pellegrino Musto
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e800 (2022)
Externí odkaz:
https://doaj.org/article/2a6262732a324e758a9662a8e4cd2c92
Autor:
I. Attolico, F. Tarantini, C. P. Schifone, A. Mestice, G. De Tullio, C. Derosa, F. Carbone, A. Negri, P. Carluccio, M. Delia, F. Albano, A. M. V. Larocca, P. Stefanizzi, L. Vimercati, S. Tafuri, P. Musto
Publikováno v:
HemaSphere, Vol 6, Pp 1204-1205 (2022)
Externí odkaz:
https://doaj.org/article/f67e5df1d545449c8dcadc7e8d6293fd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Microalgae Valorisation via Accelerated Solvent Extraction: Optimization of the Operative Conditions
Autor:
A. Molino, J. Rimauro, P. Casella, A. Cerbone, V. Larocca, D. Karatza, E. Hristoforou, S. Chianese, D. Musmarra
Publikováno v:
Chemical Engineering Transactions, Vol 65 (2018)
The valorisation of microalgae for the production of valuable biomolecules, for their use in several fields, such as cosmetic, pharmaceutical and animal food, by applying technologies able to avoid any kind of alteration of the biomolecule, is becomi
Externí odkaz:
https://doaj.org/article/2387bb3a9a5a45cbb252bdbe5ffdb3d2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lisa B. E. Shields, David A. Sun, Hilary A. Highfield, Renato V. LaRocca, Aaron C. Spalding, Kaylyn D. Sinicrope, Yi Ping Zhang, Christopher B. Shields
Publikováno v:
Journal of Neurosurgery: Case Lessons. 3
BACKGROUND Ependymomas are the most frequent tumors of the adult spinal cord, representing 1.9% of all central nervous system tumors and 60% of spinal cord tumors. Spinal ependymomas are usually solitary, intramedullary lesions. While intradural extr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84e786ae79391d9d0157df465921a43f
https://doi.org/10.3171/case22141
https://doi.org/10.3171/case22141
Publikováno v:
Journal of palliative medicine. 25(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d87c3a3be055ef2d0a1491e4e77996
https://pubmed.ncbi.nlm.nih.gov/35475758
https://pubmed.ncbi.nlm.nih.gov/35475758
Autor:
Renato V. LaRocca, Robert O Dillman, Gabriel Nistor, Mehrdad Abedi, Jose Carrillo, Thomas H. Taylor, Frank P.K. Hsu, Christopher Duma, Robert Aiken, Santosh Kesari, David Piccioni, Candace Hsieh, Xiao-Tang Kong, Daniela A. Bota
Publikováno v:
Neuro Oncol
Neuro-Oncology, vol 23, iss Supplement_6
Neuro-Oncology, vol 23, iss Supplement_6
In primary glioblastoma (GBM), overall survival (OS) is poor despite standard aggressive therapy. Adjunctive AV-GBM-1 vaccine immunotherapy may improve OS. In this multi-institutional phase II trial, key eligibility criteria for intent-to-treat (ITT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6bc93a34830b30cc812ef84e13606b8
https://europepmc.org/articles/PMC8598812/
https://europepmc.org/articles/PMC8598812/
Autor:
Thomas H. Taylor, Renato V. LaRocca, Daniela A. Bota, Jose Carrillo, Mehrdad Abedi, Robert O. Dillman, David Piccioni, Xiao-Tang Kong, Candace Hsieh, Gabriel Nistor, Christopher Duma, Robert Aiken, Santosh Kesari, Frank P.K. Hsu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundStandard therapy of glioblastoma (GBM), which includes maximum safe resection, concurrent radiation therapy and temozolomide chemotherapy (RT/TMZ) followed by maintenance TMZ, is associated with poor overall survival (OS). Adding treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cbd609fdf83a1c1ab4e005e9fa669f
https://doaj.org/article/880199fb78a646b7bc992874e012370a
https://doaj.org/article/880199fb78a646b7bc992874e012370a